Join
Live feed
·
INSIDERFilingvia Quantisnow
aTyr Pharma Inc. logo

General Counsel Denyes Nancy sold $3,398 worth of shares (899 units at $3.78) and converted options into 2,687 shares, increasing direct ownership by 7% to 26,555 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATYR· aTyr Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATYR (aTyr Pharma Inc.) and more on Quantisnow.

General Counsel Denyes Nancy sold $3,398 worth of shares (899 units at $3.78) and converted options into 2,687 shares, increasing direct ownership by 7% to 26,555 units (SEC Form 4) | Quantisnow